Atypical ductal breast hyperplasia
Atypical ductal hyperplasia
Atypical glandular cells
Atypical hyperplasia
Atypical lobular hyperplasia
Atypical mole
Atypical squamous cells of undetermined significance
Atypical squamous cells, cannot exclude a high-grade lesion
Atypical teratoid/rhabdoid tumor
Auditory brain stem response test
Auricular acupuncture
Aurora B/C kinase inhibitor GSK1070916A
Aurora kinase inhibitor AT9283

Anti-CD22 immunotoxin CAT-8015

Meaning of Anti-CD22 immunotoxin CAT-8015

A drug used to treat hairy cell leukemia that came back or did not get better with at least two other systemic therapies, including treatment with a purine nucleoside analog (a type of anticancer drug). Anti-CD22 immunotoxin CAT-8015 contains a monoclonal antibody called moxetumomab that binds to a protein called CD22, which is found on B cells (a type of white blood cell) and some types of leukemia cells. It also contains a bacterial toxin called PE38, which may help kill cancer cells. Anti-CD22 immunotoxin CAT-8015 is a type of immunotoxin. Also called CAT-8015, Lumoxiti, and moxetumomab pasudotox.

ALSO SEE:  AC-T regimen

Leave a Reply

Your email address will not be published. Required fields are marked *